Area of research
Behavioral Neuroscience · Biological Psychiatry
Research interest
Research interests include Medicine, Translocator protein, Psychology, Neuroscience, Depression (economics), and Tinnitus.
Neuroactive steroids for the treatment of depression and anxiety: gaps and promises
Electroconvulsive Therapy Changes Peripheral Blood Neurotrophic and Inflammatory Markers in Depressed Patients
Data integration with Fusion Searchlight: Classifying brain states from resting-state fMRI
Innovative pharmacological depression treatment
Neuroactive steroids role in mood disorders and PTSD
Neuropathophysiological changes associated with mirtazapine treatment response in major depressive disorder: insights into bottom-up dopaminergic pathways and prefrontal control networks
Associations between sex, body mass index and the individual microglial response in Alzheimer’s disease
Serotonin effects on human iPSC-derived neural cell functions: from mitochondria to depression
Mitochondrial and Cellular Function in Fibroblasts, Induced Neurons, and Astrocytes Derived from Case Study Patients: Insights into Major Depression as a Mitochondria-Associated Disease
Enhancing predictability of IDH mutation status in glioma patients at initial diagnosis: a comparative analysis of radiomics from MRI, [18F]FET PET, and TSPO PET
Neuroinflammation Parallels <scp>18F</scp> ‐ <scp>PI</scp> ‐2620 Positron Emission Tomography Patterns in Primary 4‐Repeat Tauopathies
Local and global effects of sedation in resting-state fMRI: a randomized, placebo-controlled comparison between etifoxine and alprazolam
Neurosteroids and translocator protein 18 kDa (TSPO) ligands as novel treatment options in depression
The translocator protein 18kDa ligand etifoxine in the treatment of depressive disorders—a double-blind, randomized, placebo-controlled proof-of-concept study
Regional desynchronization of microglial activity is associated with cognitive decline in Alzheimer’s disease
GRT-X Stimulates Dorsal Root Ganglia Axonal Growth in Culture via TSPO and Kv7.2/3 Potassium Channel Activation
Serotonin Effects on Human iPSC-Derived Neural Cell Functions: from Mitochondria to Depression
Specificity of the short‐story task for autism diagnosis when controlling for depression
A comprehensive functional investigation of the human translocator protein 18 kDa (TSPO) in a novel human neuronal cell knockout model: from molecule to depression
Translocator protein and neurodegeneration: insights from Alzheimer’s disease
From Cell to Circuit: Investigating Functional Topological Changes in iPSC-derived Neuronal Networks in Major Depressive Disorder
Investigating the Influence of Cues on Pain Perception: A Bayesian Model Selection Approach
A Comprehensive Functional Investigation of the Human Translocator Protein 18 kDa (TSPO) in a Novel Human Neuronal Cell Knockout Model
Individual regional associations between Aβ-, tau- and neurodegeneration (ATN) with microglial activation in patients with primary and secondary tauopathies
Chronic administration of XBD173 ameliorates cognitive deficits and neuropathology via 18 kDa translocator protein (TSPO) in a mouse model of Alzheimer’s disease
Feasibility of radiomic feature harmonization for pooling of [18F]FET or [18F]GE-180 PET images of gliomas
Translocator protein (18kDA) (TSPO) marks mesenchymal glioblastoma cell populations characterized by elevated numbers of tumor-associated macrophages
Prognostic Value of TSPO PET Before Radiotherapy in Newly Diagnosed IDH–Wild-Type Glioblastoma
Association of Neurofilament Light Chain, [ <sup>18</sup> F]PI-2620 Tau-PET, TSPO-PET, and Clinical Progression in Patients With β-Amyloid–Negative CBS
Short-term effects of etifoxine on human gut microbiome in healthy men